Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-24-049162
Filing Date
2024-12-06
Accepted
2024-12-06 19:45:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 66821
  Complete submission text file 0001493152-24-049162.txt   68464
Mailing Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929
Business Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929 (866) 594-5999
PROVECTUS BIOPHARMACEUTICALS, INC. (Subject) CIK: 0000315545 (see all company filings)

EIN.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-32172 | Film No.: 241533549
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2220 SOUTHERLAND AVE KNOXVILLE TN 37919
Business Address
Pershing Edward (Filed by) CIK: 0001689739 (see all company filings)

Type: SC 13D/A